πŸ‡ΊπŸ‡Έ FDA
Patent

US 9907789

Sustained-release preparation

granted A61KA61K31/4439A61K9/2018

Quick answer

US patent 9907789 (Sustained-release preparation) held by Takeda Pharmaceutical Company Limited expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4439, A61K9/2018, A61K9/2031, A61K9/2054